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Objectives This study investigated whether the technitium-99m sestamibi (MIBI) washout rate (WR) would predict mito-
chondrial damage and myocardial dysfunction in patients with dilated cardiomyopathy (DCM).
Background Myocardial mitochondrial damage reduces adenosine triphosphate production, resulting in myocardial dysfunc-
tion. Increased myocardial 99mTc-MIBI washout is reportedly caused by mitochondrial dysfunction.
Methods Twenty DCM patients (New York Heart Association functional class I–III) underwent myocardial 99mTc-MIBI scin-
tigraphy and cardiac catheterization. Myocardial MIBI uptake was quantified as an early and delayed heart-to-
mediastinum ratio, and WR was calculated. Maximum first derivative of left ventricular (LV) pressure (LV dP/dtmax)
(an index of myocardial contractility) and LV pressure half-time (T1/2) (an index of myocardial relaxation) were calcu-
lated by the left ventricular pressure curve at baseline and during dobutamine infusion (15 g/kg/min at maxi-
mum). Endomyocardial biopsy specimens were obtained for quantitative mRNA analysis and electron micros-
copy. The patients were divided into two groups as follows: 1) group A of 10 patients showing a WR 24.3%
(median value) and 2) group B of 10 patients showing a WR 24.3%.
Results WRwas significantly correlated with the percentage changes in LV dP/dtmax (%LV dP/dtmax) (r:0.59; p 0.01) and T1/2
(r: 0.57; p  0.03) from baseline to peak dobutamine stress. The %LV dP/dtmax was significantly greater in group B
than in group A. The abundance of mRNAs for mitochondrial electron transport–related enzymes was more signifi-
cantly reduced in group B than in group A. Electron microscopy revealed significant correlations between WR and the
severity of mitochondrial damage (r: 0.88; p  0.048) and glycogen accumulation (r: 0.90; p  0.044).
Conclusions Increased 99mTc-MIBI washout may predict mitochondrial dysfunction and the impairment of myocardial contrac-
tile and relaxation reserves during dobutamine stress in DCM patients. (J Am Coll Cardiol 2013;61:2007–17)
© 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.01.074Dilated cardiomyopathy (DCM) is characterized by left
ventricular (LV) dilatation and myocardial systolic dysfunc-
tion (1,2). The recent advancement in pharmacological
treatments, such as treatments with renin-angiotensin-
aldosterone system inhibitors or beta-blockades, provides
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20, 2012, accepted January 8, 2013.significant beneficial effects for patients with DCM. How-
ever, some DCM patients fail to show significant responses
to these treatments, resulting in a poor prognosis. The
prevalence of severe myocardial damage, including mito-
See page 2018
chondrial functional failure, is thought to be associated with
a poor prognosis. Accordingly, it is important to clarify the
underlying pathophysiological mechanisms involved in re-
fractoriness to any treatments.
Myocardial technitium-99m–labeled sestamibi (MIBI) is
commonly used as a myocardial perfusion imaging tracer for
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Mitochondrial Dysfunction in DCM Patients May 14, 2013:2007–17detecting significant coronary ar-
tery disease. Approximately 90%
of myocardial MIBI is localized
within a mitochondrial fraction.
Myocardial MIBI uptake, which
is positively charged electrically,
depends on a strong negative charge
in mitochondrial membranes (3,4).
A lack of MIBI uptake has been
reported in some experimental stud-
ies (5,6). In addition, an increased
MIBI washout is thought to be re-
lated to impaired mitochondrial
function coexisting with myocar-
dial damage (7,8). An increased
myocardial MIBI washout was of-
ten reported in patients with myo-
cardial infarction (9,10) or cardio-
myopathy (11–14). We previously
reported that increased MIBI
washout was associated with ab-
normal myocardial properties
linked to myocardial mitochon-
drial damage in patients with non-
obstructive hypertrophic cardio-
myopathy (15,16).
In the present study, we inves-
tigated the relationship between
myocardial MIBI washout, myo-
cardial functional properties, mi-
tochondrial messenger ribonu-
cleic acid (mRNA) expression,
and mitochondrial structural
configuration in DCM patients.
Methods
Study population. A total of 20
DCM patients (11 men and 9
women; mean age: 50  13 years;
and mean LV ejection fraction
[LVEF]: 34 9%) were studied. DCM was diagnosed on the
asis of clinical, electrocardiographic and echocardiographic
ndings according to previously proposed diagnostic criteria
17). Patients were excluded if they showed prior evidence of
oronary artery disease, primary valvular disease, essential or
econdary hypertension, chronic atrial fibrillation, or diabetes
ellitus. All patients underwent coronary angiography to
xclude those with significant coronary artery disease. An
ndomyocardial biopsy was also performed to assess the reverse
ranscriptase–polymerase chain reaction (RT-PCR) analysis,
nd electron microscopy was subsequently conducted. All
atients underwent cardiac catheterization analysis at rest
nd under dobutamine stress, as well as myocardial MIBI
cintigraphy at rest. The study protocol was approved by the
Abbreviations
and Acronyms
BNP  brain natriuretic
peptide
COX5B  cytochrome c
subunit 5B
DCM  dilated
cardiomyopathy
GAPDH  glyceraldehyde-3-
phosphate dehydrogenase
H/M  heart-to-mediastinal
ratio
-KGDH  alpha-
ketoglutarate
dehydrogenase
LV  left ventricular
LV dP/dtmax  maximum
first derivative of left
ventricular pressure
LVEF  left ventricular
ejection fraction
MIBI  sestamibi
mRNA  messenger
ribonucleic acid
NADH  nicotinamide
adenine dinucleotide
NDUFV3  nicotinamide
adenine dinucleotide
dehydrogenase-ubiquinone
flavoprotein 3
NYHA  New York Heart
Association
RT-PCR  reverse
transcriptase–polymerase
chain reaction
SPECT  single photon
emission tomography
T1/2  left ventricular
pressure half-time
WR  washout ratethics review board at the Nagoya University School of LMedicine, and written informed consent was obtained from
all patients.
Myocardial MIBI scintigraphy. Myocardial MIBI scin-
tigraphy was conducted at rest. Six hundred megabecquerels
of MIBI tracer was injected in each patient intravenously.
The initial images were acquired 60 min after tracer
injection, and the delayed images were initiated 4 h later. A
Toshiba gamma triple-head rotation camera (GCA9300,
Toshiba Inc., Tokyo, Japan) equipped with a low-energy,
high-resolution collimator was used for single-photon emis-
sion computed tomography (SPECT) imaging. Projection
images were obtained over a 360° arc at an acquisition time
of 20 s per image. A 20% symmetric window centered at
140 KeV was applied. Projected image data were transferred
to a dedicated computer using a 64  64 matrix size. For
PECT reconstruction, Butterworth filter served as prefilter
nd Ramp filter as back-projection filter, with a cutoff
requency of 0.32 cycles/pixel and an order of 8, were used
ithout correction for attenuation or scatter. Tomographic
lices were reconstructed relative to the anatomic axis of the
eft ventricle. The vertical and horizontal long-axis and
hort-axis slices were then generated.
For quantitative analysis, the early and delayed heart-to-
ediastinal ratio (H/M) and global WR were calculated.
he region of interest (ROI) on the planar imaging was
anually set over the whole heart and a rectangular ROI on
he upper mediastinum. The H/M was calculated as (Count
ensity of the whole LV)/(Count density of the mediasti-
um). The global WR was also calculated on the planar
mage as [(Initial H–Initial M)–(Delayed H–Delayed M)
C]/(Initial H–Initial M)  100, where H indicates mean
eart counts, M indicates mean mediastinal counts, and DC
ndicates decay coefficiency. The normal values of MIBI
R, early H/M, and delayed H/M of the age-matched
ontrol group (10 subjects; 9 men; age: 56 9 years; LVEF:
0  7%) were 11  5%, 3.5  0.3, and 3.1  0.3,
espectively.
chocardiography. Echocardiography was performed us-
ng a Sonos 2500 ultrasound system (Hewlett-Packard,
ndover, Massachusetts) equipped with a 2.5- to 3.5-
Hz transducer. The LV end-diastolic dimension, LV
nd-systolic dimension, interventricular septal thickness,
osterior wall thickness, and LVEF were measured on
he M-mode of the long-axis image according to stan-
ard criteria recommended by the American Society of
chocardiography (18).
ardiac catheterization and endomyocardial biopsy. Biven-
ricular catheterization was performed using the standard
echniques. In the left heart catheter, a 6-F fluid-filled
igtail catheter with a high-fidelity micromanometer (CA-
1000-PLB Pressure-tip Catheter; CD Leycom, Zoeter-
eer, the Netherlands) was positioned in the left ventricle
or the measurement of LV pressure. Micromanometer
ressure signals and standard electrocardiograms were con-
inuously recorded with a multichannel recorder online. The
V pressure signals were digitized at 3-ms intervals and
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May 14, 2013:2007–17 Mitochondrial Dysfunction in DCM Patientswere analyzed throughout the procedure with software
developed in-house and a 32-bit microcomputer system.
The LV pressure and heart rate (HR) were determined as
averages of at least 15 consecutive beats. The LV end-
diastolic pressure, the maximum first derivative of LV
pressure (LV dP/dtmax) as an index of contractility, and the
V pressure half-time (T1/2) as an index of LV isovolumic
elaxation were measured both at baseline and under dobut-
mine stress as previously described (19,20). In the right
eart catheter, a 7-F triple-lumen Swan-Ganz thermodilu-
ion catheter was positioned in the right pulmonary artery to
easure the pulmonary arterial wedge pressure and cardiac
ndex. For a pharmacological stress test, dobutamine was
ntravenously injected with an infusion pump at a starting
ose of 5 g/kg/min, followed by incremental doses of 10
g/kg/min and 15 g/kg/min as previously described
(19,20). The percentage changes in the LV dP/dtmax (%LV
P/dtmax) and T1/2 (%T1/2) from the baseline to peak values
under dobutamine stress were also calculated.
An endomyocardial biopsy was performed on all patients
to exclude myocarditis (according to the Dallas criteria) as
well as specific heart muscle diseases detected by an electron
microscopic analysis. Biopsy specimens were obtained from
the septum of the right ventricle with a 6-F bioptome. The
tissue was fixed immediately in 10% buffered formalin and
embedded in paraffin. Three or four specimens were ana-
lyzed for each patient.
RT-PCR. Total mRNA was isolated from 1 to 2.5 mg of
frozen biopsy specimens of all patients with the use of an
RNeasy Fibrous Tissue Mini-Kit (Qiagen, Valencia, Cali-
fornia). The RNA was subjected to reverse transcription
with an RNA PCR Core Kit (Applied Biosystems, Foster
City, California), and the resulting cDNA was subjected to
quantitative PCR analysis with an ABI 7300 Real-Time
PCR System (Applied Biosystems) as previously described
(21). The sequences of primers and TaqMan probes speci-
fic to the human alpha-ketoglutarate dehydrogenase
(-KGDH), nicotinamide adenine dinucleotide (NADH)
dehydrogenase (ubiquinone) flavoprotein 3 (NDUFV3) (com-
plex I), cytochrome c oxidase subunit 5B (COX5B) (respira-
tory complex IV), P-glycoprotein, and glyceraldehydes-3-
phosphate dehydrogenase (GAPDH) were described
previously (15). The amount of mitochondrial protein mRNAs
in endomyocardial biopsy specimens was determined by RT-
PCR analysis and was normalized relative to that of GAPDH
mRNA.
Electron microscopic analysis of myocardial mitochon-
dria. Electron microscopy was performed on six patients
(four patients of group A and two patients of group B).
Biopsy samples were cut into1-mm3 slices, and were fixed
rst for 24 h with 2% glutaraldehyde in 0.16 M sodium
hosphate (pH 7.2) and then for 1 h with 1% osmium
etroxide. The fixed tissues were dehydrated in a graded
eries of ethanol solutions before exposure to propylene
xide and embedding in Epon. Sections were cut at a
hickness of 60 to 70 nm, stained with uranyl acetate andead citrate, and observed with a JEM-1400 transmission
lectron microscope (JEOL, Tokyo, Japan) operating at 100 kV.
he quantitation of mitochondrial numbers and sizes was
erformed at a magnification of 8,000 by counting the
orresponding number of pixels using Adobe Photoshop ver-
ion 7.0.1. A total of 120 mitochondrial cross-sectional areas
rom six sections were measured for each patient, and histo-
rams were generated separately for each group of patients.
The severity of the mitochondria degeneration was ana-
yzed, and the mitochondria were examined in accordance
ith the severity of the degeneration of cristae, as follows:
he mitochondria with a normal form were denoted as A;
hose with 1% to 25% of degenerated cristae, B; those with
6% to 50%, C; those with 51% to 75%, D; and those with
6% to 100%, E. Each fraction of mitochondria was
ounted in one field of view six times and averaged for each
atient. Finally, a mitochondria damage index (MDI) was
alculated as follows:
MDI  1  a/100  2  b⁄100  3  c⁄100 
4  d⁄100  5  e⁄100
(A : 1 point; a %, B : 2 points; b %,
C: 3 points; c %, D : 4 points; d %, E : 5 points; e %)
The glycogen accumulation and lipid droplets were also
counted and averaged in the same way.
Blood sampling. Each blood sample was immediately
placed on ice and centrifuged at 4°C. The plasma levels of
neurohumoral factors, such as norepinephrine, epinephrine,
brain natriuretic peptide (BNP), renin, and aldosterone,
were also measured. Plasma norepinephrine levels were
measured using high-performance liquid chromatography.
Plasma BNP levels were measured with a specific radioim-
munoassay for human BNP.
Patient classification. Patients were classified into two
groups according to the median value of WR, as follows:
group A consisted of 10 patients showing a WR of 24.3%
(a median value of WR); group B consisted of 10 patients
showing a WR of 24.3%.
Statistical analysis. Data were presented as the mean 
SD or the median value (quartiles 1–3). Comparisons of
data between the two groups were analyzed using the
Student t test, whereas BNP, epinephrine, renin, and
aldosterone, which were not normally distributed, were
compared with a nonparametric Mann-Whitney U test.
The fractions of sex, New York Heart Association
(NYHA), and medications between the 2 groups were
compared with a chi-square test or a Fisher exact test as
appropriate. The relationship of each parameter was deter-
mined using Spearmen’s rank correlation coefficients. A p of
0.05 was considered statistically significant.
Results
Patient characteristics. The patient characteristics are pre-
sented in Table 1. Their mean age was 50 13 years. Eight
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Mitochondrial Dysfunction in DCM Patients May 14, 2013:2007–17patients were classified as NYHA functional class I, 10
patients as NYHA class II, and 2 patients as NYHA class
III. The mean early and delayed H/Ms were 2.8  0.5 and
.9 0.5, respectively. The mean and median values of WR
ere 24.4  8.4% and 24.3%, respectively. The LV end-
iastolic diameter and LV end-systolic diameter derived
rom echocardiography were 64  7 mm and 52  9 mm,
espectively, suggesting LV dilation. The interventricular
eptal thickness and posterior wall thickness were 9 2 mm
nd 10  3 mm, respectively. The LVEF was reduced to a
ean value of 33  11%. The plasma BNP and norepineph-
ine levels were 74 (51 to 306) pg/ml and 671  41 pg/ml,
espectively, suggesting elevated neurohumoral factors.
omparison of parameters between 2 groups. Compari-
ons of parameters are presented in Table 2. The LV
nd-diastolic diameter (67  8 mm vs. 60  4 mm; p 
.04) and end-systolic diameter (57  10 mm vs. 47  5
m; p  0.002) were significantly greater in group B than
Patient CharacteristicsTable 1 Patient Characteristics
Age, yrs 50 13
Sex
Male 11
Female 9
NYHA functional class
I 8
II 10
III 2
Echocardiography
LVEF (%) 33 11
LVDd (mm) 64 7
LVDs (mm) 52 9
IVST (mm) 9 2
LVPWT (mm) 10 3
E/A 1.1 0.4
DcT (ms) 281 28
Cardiac catheterization
LVEDP (mm Hg) 16.5 9.6
PAWP (mm Hg) 12.2 6.9
CO (l/min) 5.1 0.9
CI (l/min/m2) 2.8 0.6
Neurohumoral factors (pg/ml)
BNP 74 (51–306)
Epinephrine 34 (2–43)
Norepinephrine 671 41
Renin 14 (8–19)
Aldosterone 192 (12–228)
Myocardial scintigraphy
Early H/M 2.8 0.5
Delayed H/M 2.9 0.6
WR (%) 24.4 8.4
Values are mean  SD, n, or median (quartiles 13).
BNP  brain natriuretic peptide; CI  cardiac index; CO  cardiac output; DcT  deceleration
ime; E/A  E to A wave ratio; H/M  heart-to-mediastinal ratio; IVST  interventricular septal
hickness; LVDd  left ventricular end-diastolic dimension; LVDs  left ventricular end-systolic
dimension; LVEDP  LV end-diastolic pressure; LVEF  left ventricular ejection fraction; LVPWT 
LV posterior wall thickness; NE  norepinephrine; NYHA  New York Heart Association; PAWP 
pulmonary arterial wedge pressure; WR  washout rate.n group A. The plasma levels of noradrenaline were moreignificantly elevated in group B than in group A (862 
20 pg/ml vs. 457  286 pg/ml; p  0.03).
elationship between MIBI WR and hemodynamic
hanges. The baseline values of LV dP/dtmax and T1/2 were
similar in the two groups. The peak values of LV dP/dtmax
at 15 g/kg/min of dobutamine stress, and %LV dP/dtmax
were significantly lower in group B than in group A
(1,757 703 mm Hg/s vs. 3,160 1,238 mm Hg/s [p 0.02]
and 87  42% vs. 148  56% [p  0.004], respectively).
The %T1/2 tended to be lower in group B than in group A
37  15% vs. 48  9%; p  0.08) (Table 2).
Although the MIBI WR did not significantly correlate
ith the baseline LV dP/dtmax and T1/2, it did significantly
orrelate with the %LV dP/dtmax and %T1/2 (r:0.59 [p 0.01]
nd r: 0.57 [p  0.03], respectively) (Fig. 1). No signif-
cant correlations were observed between early or delayed
/M and %LV dP/dtmax or %T1/2.
xpression of mitochondria mRNA. The abundance of
RNAs for mitochondrial electron transportrelated en-
ymes, such as -KGDH, NDUFV3, and COX5B, was
ignificantly lower in group B than in group A (0.43  0.21
s. 0.95  0.40 [p  0.0001]; 0.52  0.21 vs. 1.24  0.47
[p  0.0001]; and 0.45  0.14 vs. 0.95  0.37 [p 
0.0003], respectively) (Fig. 2). Significant inverse correlations
were noted between MIBI WR and -KGDH/GAPDH,
NDUFV3/GAPDH, and COX5B/GAPDH (r: 0.78 [p 
.0006]; r: 0.76 [p  0.001]; and r: 0.62 [p  0.007],
espectively), whereas no significant correlation was seen be-
ween MIBI WR and P-glycoprotein/GAPDH (Fig. 3).
elationship between MIBI WR and electron micro-
copic findings. Ventricular biopsy specimens from 6 pa-
ients (4 patients of group A and 2 patients of group B) were
vailable for electron microscopic analysis. A significant corre-
ation was observed between MIBI WR and MDI
r: 0.88; p  0.048), but none was observed between MIBI
R and the total number of mitochondria (Fig. 4A). A
ignificant correlation was found between the MIBI WR and
lycogen-positive areas (r: 0.90; p 0.044), whereas none was
bserved between MIBI WR and lipid droplets (Fig. 4B).
ase presentation. Two typical cases are shown in Figure 5.
Figure 5A shows a 66-year-old man without a globally
increased MIBI WR and with a favorably increased %LV
dP/dtmax and a relatively preserved mitochondrial configu-
ation and small areas of glycogen accumulations in electron
icroscopy. Figure 5B shows a 45-year-old woman with an
ncreased global MIBI WR, a gentle increase in %LV
P/dtmax in response to dobutamine, and numerous dam-
aged mitochondria and glycogen and lipid droplets on
electron microscopy.
Discussion
The present study demonstrated that an increased myocar-
dial MIBI washout was correlated with a decrease in
myocardial mitochondrial mRNA expression or an abnor-
mal morphology of mitochondria in patients with DCM. In
2011JACC Vol. 61, No. 19, 2013 Hayashi et al.
May 14, 2013:2007–17 Mitochondrial Dysfunction in DCM PatientsComparison of Each Parameter Between Groups A and BTable 2 Comparison of Each Parameter Between Groups A and B
Parameter Group A (n  10) Group B (n  10) p Value
Age (yrs) 51 15 48 10 0.61
Sex 0.054
Male 7 4
Female 3 6
NYHA functional class —
I 4 4
II 6 4
III 0 2
BMI (kg/m2) 25.3 4.3 25.9 5.7 0.80
Echocardiography
LVEF (%) 37 7 31 10 0.12
LVDd (mm) 60 4 67 8 0.04
LVDs (mm) 47 5 57 10 0.002
IVST (mm) 10 3 8 2 0.14
LVPWT (mm) 11 4 9 2 0.23
E/A 0.9 0.3 1.2 0.4 0.15
DcT (ms) 210 55 208 65 0.96
Myocardial scintigraphy
Early H/M 3.0 0.5 2.8 0.5 0.40
Delayed H/M 3.2 0.5 2.8 0.6 0.19
Neurohumoral factors (pg/ml)
BNP 74 (32–125) 160 (53–312) 0.27
Epinephrine 25 (20–37) 37 (29–47) 0.36
Norepinephrine 457 286 862 420 0.03
Renin 14 (7–17) 15 (9–32) 0.49
Aldosterone 146 (122–244) 206 (126–226) 0.95
Medication
Diuretic 7 5 0.21
Beta-blocker 8 6 0.20
ACE-I or ARB 8 6 0.20
Statin 1 1 1.00
Cardiac catheterization
LV dP/dtmax (mm Hg/s)
Baseline 1,228 397 961 302 0.11
DOB 5 g/kg/min 1,723 734 1,199 465 0.08
DOB 10 g/kg/min 2,364 1,139 1,574 610 0.09
DOB 15 g/kg/min 3,160 1,238 1,757 703 0.01
%
DOB 5 g/kg/min 40 (25–48) 14 (9–27) 0.16
DOB 10 g/kg/min 84 53 62 31 0.30
DOB 15 g/kg/min 148 56 87 42 0.02
T1/2 (ms)
Baseline 41.6 5.3 42.9 11.3 0.75
DOB 5 g/kg/min 36.5 8.7 38.0 11.7 0.75
DOB 10 g/kg/min 27.8 5.5 31.4 12.6 0.43
DOB 15 g/kg/min 21.3 3.9 28.9 11.6 0.09
%
DOB 5 g/kg/min 13 (4–23) 10 (3–21) 0.93
DOB 10 g/kg/min 31 15 28 14 0.73
DOB 15 g/kg/min 48 9 37 15 0.08
LVEDP (mm Hg) 16.8 7.1 16.1 12.1 0.88
PAWP (mm Hg) 11.3 5.5 13.0 8.3 0.60
CO (l/min) 5.1 1.0 5.1 1.0 0.96
CI (l/min/m2) 2.8 0.5 2.9 0.6 0.64
Values are mean  SD, n, or Median (quartiles 13).
ACE-I  angiotensin-converting enzyme inhibitor; ARB angiotensin II receptor blocker; BMI body mass index; DOB dobutamine; LV dP/dtmax
maximum first derivative of LV pressure; T1/2  LV pressure half-time; other abbreviations as in Table I.
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Mitochondrial Dysfunction in DCM Patients May 14, 2013:2007–17addition, a myocardial MIBI washout was also correlated
with an impairment in the myocardial contractile and
relaxation reserves.
An increased myocardial MIBI washout is thought to
reflect an impairment in mitochondrial function as a result
of a decrease in the mitochondrial transmembrane potential
(4,7). In the present study, we examined the expression of
several mitochondrial protein mRNAs involved in the
myocardial ATP production of DCM patients. Mitochon-
drial ATP production is mainly generated by the tricarbox-
ylic acid cycle (TCA cycle) in the mitochondrial matrix and
the electron transport chain in the mitochondrial mem-
brane. -KGDH is a key enzyme in the production of
ADH by the TCA cycle and regulates the mitochondrial
lectron transport system (22). NADHubiquinone oxi-
oreductase (complex I) and cytochrome c oxidase (complex
V) are the main components that remove protons in the
Figure 1 Relationship Between MIBI WR and Hemodynamic Ch
(A) A significant inverse correlation was observed between technitium-99m sestam
of LV pressure (LV dP/dtmax) from baseline to peak (15 g/kg/min) dobutamine s
changes in LV pressure half-time (T1/2) from baseline to peak (15 g/kg/min) dobitochondrial respiratory chain. Abnormalities of the mi-ochondrial respiratory chain were detected in patients with
eart failure and were attributed to a reduction in the
ctivity rates of the electron transport chain (23). Electron
ransportation is accompanied by the phosphorylation of
denosine diphosphate by the movement of protons though
he inner mitochondrial membrane from the matrix to the
ntermembrane space. This process generates an electrical
radient across the inner mitochondrial membrane, which
as a more negative potential on the inside than on the
utside of the membrane. In the present study, MIBI WR
nversely correlated with the abundance of mRNA expres-
ion in -KGDH, NDUFV3, and COX5B. These findings
ay suggest that the production of NADH by -KGDH,
as well as that of NADH by NDUFV3 or COX5B, plays a
very important role in these enzymes on energy metabolism.
A decrease in mitochondrial enzyme gene expression was
associated with a reduction in the mitochondrial transmem-
s From Baseline to Peak Dobutamine Stress
IBI) washout rate (WR) and percentage changes (%) in maximum first derivative
(B) A significant inverse correlation was observed between MIBI WR and %
ne stress.ange
ibi (M
tress.
utamibrane potential (24,25), which affects the mitochondrial
2013JACC Vol. 61, No. 19, 2013 Hayashi et al.
May 14, 2013:2007–17 Mitochondrial Dysfunction in DCM PatientsFigure 2 Comparison of Mitochondrial mRNA Expression Between the 2 Groups
(A to D) Alpha-Ketoglutarate dehydrogenase (-KGDH), nicotinamide adenine dinucleotide dehydrogenase-ubiquinone flavoprotein 3 (NDUFV3),
and cytochrome c subunit 5B (COX5B) were significantly lower in group B than in group A.Figure 3 Relationship Between MIBI WR and Expression of Mitochondrial mRNA
(A to D) Significant inverse correlations were observed between MIBI WR and -KGDH/glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
NAUFV3/GAPDH, or COX5B/GAPDH. Abbreviations as in Figures 1 and 2.
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Mitochondrial Dysfunction in DCM Patients May 14, 2013:2007–17function. Those abnormalities may be attributed to an
increased MIBI washout observed in our study.
Our electron microscopic findings revealed that the se-
verity of degeneration in the cristae of mitochondria in the
myocardium was correlated with myocardial MIBI WR. On
the other hand, no significant relationship was seen between
the numbers of mitochondria and MIBI WR. Our previous
electron microscopic study in patients with hypertrophic
cardiomyopathy demonstrated that the number of mito-
chondria and the variance in mitochondrial size were
increased in patients with an impaired myocardial contrac-
tile or relaxation reserve (15). Overproliferated and prema-
ture mitochondria exhibit an inappropriate ATP produc-
tion, which would result in the impairment of myocardial
contractile or relaxation reserves in patients with hypertro-
phic cardiomyopathy. The present study did not show the
number of changes in mitochondria, but showed instead the
ultrastructural abnormalities of mitochondria, which may
lead to myocardial dysfunction in DCM patients. More-
Figure 4 Relationship Between MIBI WR and Parameters of Ele
Significant correlations were observed between MIBI WR and (A) the mitochondria
whereas no significant correlation was seen between MIBI WR and (B) total numb
other abbreviations as in Figure 1.over, we observed an increased accumulation of glycogen insome DCM patients, and the glycogen accumulations were
correlated with myocardial MIBI WR. Furthermore, an
increased glycogen accumulation was more frequently ob-
served in the areas around severely degenerated and disor-
ganized mitochondria. These findings were in accordance
with the results previously demonstrated—that an increased
glycogen accumulation was induced by an impaired ATP
utilization in patients with more advanced cardiomyopathy
(15,21,26). In addition, though lipid accumulation was
frequently observed in all patients, it did not correlate with
myocardial MIBI WR. Lipid accumulation in the myo-
cardium would reflect the abnormality of lipid metabo-
lism. An increased lipid accumulation in the myocardium
results in lipotoxicity, leading consequently to cardiomy-
ocyte apoptosis (27).
In the present study, the baseline parameters of echocar-
diography or cardiac catheterization did not correlate with
myocardial MIBI WR, but rather with the percentage
changes in an index of myocardial contractility or relaxation.
n Microscopic Findings
ge index (MDI) and (C) glycogen-positive areas,
itochondria or (D) lipid droplets. Mit.  mitochondria;ctro
dama
er of mMoreover, myocardial MIBI WR was inversely correlated
2015JACC Vol. 61, No. 19, 2013 Hayashi et al.
May 14, 2013:2007–17 Mitochondrial Dysfunction in DCM PatientsFigure 5 Representative Case of Each Study Group
Two typical cases are presented. (A) A 66-year-old man shows no global increased MIBI WR (19.4%). An increased washout was observed in the small anteroapical area
(red arrows) on MIBI single-photon emission tomography (SPECT). The %LV dP/dtmax was favorably increased (5 g/kg/min: 28%; 10 g/kg/min: 92%; 15 g/kg/min:
139%). Electron microscopy revealed a relatively preserved mitochondrial configuration as well as a small amount of glycogen accumulations (green arrows) and lipid
droplets (yellow arrows). (B) A 45-year-old woman exhibited an increased MIBI WR (28.3%). An increased washout was particularly observed in the anteroseptal to the
inferoseptal wall on MIBI SPECT. The %LV dP/dtmax showed a subtle increase in response to dobutamine (5 g/kg/min: 0.5%; 10 g/kg/min: 41%; 15 g/kg/min:
78%). Electron microscopy revealed many damaged mitochondria (blue arrows) and glycogen accumulations (green arrows). Abbreviations as in Figure 1.
r
O
r
m
p
i
t
M
n
S
r
M
1
1
2016 Hayashi et al. JACC Vol. 61, No. 19, 2013
Mitochondrial Dysfunction in DCM Patients May 14, 2013:2007–17with myocardial contractile reserves during dobutamine
stress. An impairment in myocardial contractile reserves has
been frequently reported to be an important predictor for
prognosis or detecting responder to medical therapy in
DCM patients (28,29). It is reported that an impairment of
the myocardial reserve is related to the abnormalities of
Ca2	-handling or to an impairment of the mitochondrial
espiratory process in cardiomyopathy patients (15,19,30).
ur results demonstrating that myocardial MIBI WR
eflects an impairment in myocardial functional reserves and
itochondrial dysfunction or structural abnormalities may
rovide a clue to better understanding the pathophysiolog-
cal mechanisms underlying the refractoriness to medical
reatments or poor prognoses in DCM patients. Myocardial
IBI scintigraphy may prove to be a useful tool for a
oninvasive assessment of the prognosis in DCM patients.
tudy limitations. The patient population was very small,
esulting in the absence of a significant correlation between
IBI WR and the baseline LV dP/dtmax or T1/2. A
sufficient amount of ventricular tissue for the analysis of
electron microscopy was not obtained from all patients. In
addition, follow-up data were not examined in this popu-
lation, so we were not able to assess whether MIBI WR
would be an independent predictor for disease severity or
prognosis using a multivariate analysis. Furthermore, precise
mitochondrial functions, such as mitochondrial respiration
(e.g., intramyocellular triglyceride levels, respiratory ex-
change ratio, citrate synthase activity), were not directly
assessed. These issues warrant further investigations in a
larger population.
Although the association of focal MIBI WR with hemo-
dynamic data is of interest, focal myocardial MIBI WR was
not investigated. However, different from other cardiac
diseases, a diffuse increase in washout is commonly observed
in DCM. Because the present study aimed to investigate the
relationship between global functional data and global
scintigraphic parameters, we did not assess focal WR.
We cannot conclude an increase in mitochondrial density
in more advanced cases, but this issue is very important and
interesting. The mitochondrial density may increase in more
advanced cases to compensate for the lack of cellular
respiration. Meanwhile, we think that impaired glucose
utilization in abnormal myocardium could result in an
increase of glycogen-positive area in accordance with the
mitochondrial impairment.
Ventricular biopsy specimens from six patients were avail-
able for electron microscopic analysis. Different from samples
obtained from transplanted hearts, the quantity of biopsy
specimens by bioptome is not sufficient for all PCR analyses,
electron microscopic analyses, or standard histopathologic
evaluations, such as myocardial fibrosis. Therefore, it is difficult
to analyze electron microscopy in all patients.
We obtained scintigraphic parameters from normal control
subjects. However, because we could not perform invasive
cardiac catheter studies in normal control subjects for ethical
reasons, we were unable to obtain their hemodynamic data,and so we could not compare the hemodynamic data between
normal control subjects and DCM patients.
Conclusions
An increased MIBI WR in DCM patients may predict
mitochondrial dysfunction and the impairment in myocar-
dial contractile and relaxation reserves during dobutamine
stress. Our results may well lead to clinically useful findings
to assume the responses to the optical medical treatments or
patient prognoses. However, further studies are needed to
clarify these issues in a larger population.
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